Reply

Affiliations

¹ Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.
² Jaeb Center for Health Research, Tampa, Florida. Electronic address: drcrstat8@jaeb.org.
³ Jaeb Center for Health Research, Tampa, Florida.

Comment

Susan B Bressler et al. Ophthalmology. 2017 Dec.

. 2017 Dec;124(12):e88-e89.

doi: 10.1016/j.ophtha.2017.06.026.

¹ Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.
² Jaeb Center for Health Research, Tampa, Florida. Electronic address: drcrstat8@jaeb.org.
³ Jaeb Center for Health Research, Tampa, Florida.

No abstract available

Comment on

Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab.
Bressler SB, Beaulieu WT, Glassman AR, Gross JG, Jampol LM, Melia M, Peters MA, Rauser ME; Diabetic Retinopathy Clinical Research Network. Bressler SB, et al. Ophthalmology. 2017 Apr;124(4):431-439. doi: 10.1016/j.ophtha.2016.12.005. Epub 2017 Feb 1. Ophthalmology. 2017. PMID: 28161147 Free PMC article. Clinical Trial.
Re: Bressler et al.: Factors associated with worsening proliferative diabetic retinopathy in eyes treated with panretinal photocoagulation or ranibizumab (Ophthalmology. 2017;124:431-439).
Thomas M, Rao RC, Johnson MW, Paulus YM. Thomas M, et al. Ophthalmology. 2017 Dec;124(12):e87-e88. doi: 10.1016/j.ophtha.2017.06.025. Ophthalmology. 2017. PMID: 29157435 Free PMC article. No abstract available.